Arbuckle Stuart A
- SEC CIK
- 0001557290
No open-market purchases or sales filed in the past year.
Current role at each company
- RYTM Rhythm Pharmaceuticals, Inc.Directoras of Jun 25, 2026
- PRAX Praxis Precision Medicines, Inc.Directoras of Jun 12, 2026
- ALNY Alnylam Pharmaceuticals, Inc.Directoras of May 22, 2026
- VRTX Vertex Pharmaceuticals IncEVP, COOas of Jul 2, 2025
- IMGN ImmunoGen, Inc.Directoras of Feb 12, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Arbuckle Stuart A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VRTX Vertex Pharmaceuticals Inc
EVP, COO19 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 16, 2021 (view filing) | Nov 15 | 1 day | Arbuckle Stuart AEVP, COO | SSale | −3 | $187.26 | −$561.78 | 0.0%41.1K after | 2 lots |
| May 4, 2022 (view filing) | May 2 | 2 days | Arbuckle Stuart AEVP, COO | SSale | −306 | $263.98 | −$80.8K | −0.5%64.8K after | |
| May 18, 2022 (view filing) | May 16 | 2 days | Arbuckle Stuart AEVP, COO | SSale | −133 | $251.19 | −$33.4K | −0.2%64.8K after | 7 lots |
| Aug 10, 2022 (view filing) | Aug 9 | 1 day | Arbuckle Stuart AEVP, COO | SSale | −5.69K | $300.67 | −$1.71M | −8.5%61.0K after | 2 lots |
| Aug 12, 2022 (view filing) | Aug 10 | 2 days | Arbuckle Stuart AEVP, COO | SSale | −180 | $300.40 | −$54.1K | −0.3%60.9K after | 2 lots |
| Aug 17, 2022 (view filing) | Aug 15 | 2 days | Arbuckle Stuart AEVP, COO | SSale | −22.2K | $303.93 | −$6.74M | −32.9%45.3K after | 6 lots |
| Feb 14, 2023 (view filing) | Feb 13 | 1 day | Arbuckle Stuart AEVP, COO | SSale | −4.89K | $298.92 | −$1.46M | −5.6%82.0K after | 4 lots |
| Feb 16, 2023 (view filing) | Feb 14 | 2 days | Arbuckle Stuart AEVP, COO | SSale | −6.40K | $298.68 | −$1.91M | −7.8%75.6K after | 6 lots |
| Feb 22, 2023 (view filing) | Feb 21 | 1 day | Arbuckle Stuart AEVP, COO | SSale | −2.40K | $293.75 | −$705.6K | −3.4%68.7K after | 4 lots |
| Feb 24, 2023 (view filing) | Feb 22 | 2 days | Arbuckle Stuart AEVP, COO | SSale | −2.40K | $294.33 | −$706.7K | −3.5%66.3K after | 5 lots |